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Herpesviruses appear to peacefully coexist with their natural hosts, with infection typically manifested as a benign, but
lifelong process. However, coexistence depends on active resistance by innate and specific immune defenses as revealed
in the striking virulence of herpesviruses when immunity fails. This pattern of infection is characteristic of a viral pathogen,
such as cytomegalovirus, that has evolved efficient strategies targeted at host defense systems. Targeting members of the
tumor necrosis factor (TNF)/lymphotoxin (LT) superfamily of cytokines is a strategy found in all herpesviruses, which
suggests the existence of an intimate evolutionary link in their host–parasite relationship. Here we examine some of the
strategies used by herpesvirus that target members of the TNF superfamily and discuss a recent study that revealed a novel
mechanism that links LT-related ligands and interferons (IFN) to the establishment of coexistence between herpesvirus and
its host cell. © 2001 Academic Press
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cTHE TNF SUPERFAMILY
TNF-related cytokines are recognized as crucial regu-
lators and effectors of the innate and adaptive immune
defenses (Fig. 1) (Locksley et al., 2001). Signaling path-
ays initiated by TNF-related cytokines regulate cell
eath and survival providing strong selective pressures
or viruses to evolve counterstrategies. TNF cytokines
re type II transmembrane glycoproteins that signal via
heir cognate receptors, which are single transmem-
rane domain glycoproteins. The trimeric structure of the
igand clusters the receptor, activating signaling path-
ays. The cytosolic tails of TNF receptors come in two
asic flavors, those that contain a death domain (DD) (a
a helix bundle) and others with a TRAF binding region
(a short proline-anchored peptide motif) (Wallach et al.,
1999). Receptor DD provides sites for binding of DD
containing adaptor molecules (such as FADD, Fas-asso-
ciated DD), which can then recruit initiator caspases
(caspase-8) to the receptor through protein–protein in-
teractions mediated by death effector domains. Once
recruited to the receptor, procaspase-8 is activated and
can then promote cleavage of the executioner caspases
(caspase-3 and -9), leading to apoptosis. In contrast,
members of the TRAF family of zinc RING finger proteins
link their receptors to serine kinase-dependent signaling
pathways (such as NIK or RIP), leading to the activation
of NFkB and ultimately to the expression of proinflam-1 To whom correspondence and reprint requests should be ad-
ressed. Fax: (858) 558-3595. E-mail: carl_ware@liai.org.
1matory genes, such as those encoding integrins and
chemokines. Because NFkB induces the transcription of
arious antiapoptotic gene products [including the IAPs
inhibitors of apoptosis) and cFLIP (FLICE (caspase-8)
nhibitory protein)] of this pathway, it is believed to pro-
ote cell survival. Activation of NFkB requires phosphor-
lation of the inhibitor of kB (IkB) by the IkB kinases
IKKa and b), resulting in the ubiquitination and degra-
dation of IkB and allowing for the translocation of latent,
ytosolic NFkB to the nucleus. Adding to the complexity,
many TNFR family members (TNFR1, TRAIL-R1 and -R2,
and LTbR) can activate both cell survival (NFkB-depen-
dent) and cell death signaling pathways, suggesting that
cell-specific factors, for instance the steady-state levels
of cFLIP, will effect the eventual outcome of receptor
signaling. From these data we can infer that viruses that
block host cell protein synthesis may render the infected
cell susceptible to the death-inducing activity of TNF
family ligands by allowing the apoptotic pathway to pre-
dominate in the absence of NFkB-mediated survival.
Although the complexity of receptor cross-utilization
by this group of TNF/LT-related ligands suggests func-
tional redundancy, gene deletion studies in mice re-
vealed unique and cooperating roles for these cytokines
in the immune responses. Fas ligand is used by cytotoxic
T cells as a mechanism to induce apoptosis of virus-
infected cells and is also an important mechanism that
limits the life span of effector T cells. The lymphotoxin-
ab–LTbR system controls organization of lymphoid tis-
sue, lymph nodes, and Peyer’s patches during embryo-
genesis and tertiary lymphoid structures in the adult,
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2 MINIREVIEWwhich form at sites of infection anywhere in the body.
LTab is also essential for the differentiation of NK and
NK-T cells, which are critical effector cells of innate
defenses and antiviral responses. TNF by contrast is
crucial for the activation and recruitment of inflammatory
cells, but cooperates with LTab in organizing the white
pulp in the spleen. LIGHT signaling via HVEM is one of
three evolutionarily related pathways that include the
CD27 and 41BB systems, which promote the activation of
T cells.
VIRAL STRATEGIES
Given the involvement of TNF superfamily members in
immune defenses, it is not surprising that viruses have
evolved specific genetic mechanisms that modulate
these signaling pathways. Steady progress by several
labs has identified examples in DNA and RNA viruses
that when viewed collectively target every step of the
TNF pathway, from ligand-receptor binding to signal
transduction (Fig. 2) (Gooding, 1992; Tortorella et al.,
2000). Historically, the first example of a viral gene prod-
uct inhibiting TNF was gleaned from the poxvirus ge-
FIG. 1. The immediate members of the lymphotoxin/TNF family. Memb
eceptors (indicated by arrows) are depicted in the upper diagram. The c
and TNFR1 contain death domains in their cytoplasmic tails (yellow cylinde
and HVEM bind adaptors of the TRAF family of zinc RING finger proteins.
directly involved in the activation of transcription factors AP1 and NFkB. Dnome, which encodes a secreted protein with high ho-
mology to TNFR2. The poxvirus TNF receptor orthologbinds TNF and LTa with high affinity and acts as a
ecoy receptor, which competitively blocks these ligands
rom initiating signaling via their cell surface receptors.
otably, the poxvirus’ TNF inhibitor served as the proto-
ype for the successful anti-inflammatory drug Enbrel, a
usion protein of the TNFR2 ectodomain and the Fc
egion of IgG. Other examples come from adenovirus;
ndeed the entire E3 gene region of this virus modulates
he activity of TNF family members. Adenovirus-infected
ells are resistant to apoptosis due to the loss of cell
urface expression of Fas and TRAIL receptors. The
denovirus E3-10.4K, 14.5K, and 6.7K proteins serve this
unction by forming a membrane complex that internal-
zes Fas and TRAIL receptors-1 and -2 used by cytotoxic
cells and NK cells to kill virus-infected cells. Other
xamples are found in RNA viruses. HIV nef, through its
ffect on membrane protein recycling pathways, sus-
ains the expression of cell surface TNF and LIGHT on T
ells, potentially prolonging signaling pathways (such as
FkB) that may enhance HIV transcriptional activity as
ell as regulate surrounding uninfected cells. The core
rotein of hepatitis C virus binds directly to LTbR, TNFR1,
he larger TNF superfamily that are related by their shared specificity for
receptors share a common cysteine-rich motif in their ectodomains. Fas
bind FADD and TRADD, death domain-containing adaptors. TNFR2, LTbR,
NIK are serine kinases recruited to these adaptors that activate kinases
a soluble decoy receptor that binds both LIGHT and FasL.ers of t
ognate
rs) andand Fas, potentially regulating the functions of these
receptors in a fashion not fully understood.
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3MINIREVIEWTargeting members of the TNF superfamily did not
escape the attention of herpesviruses. One of the routes
of entry used by herpes simplex virus is a TNFR family
member, HVEM. This discovery by Spear’s lab showed
that HSV envelope glycoprotein-D of herpes simplex vi-
rus (a-herpesvirus) binds HVEM and acts as a compet-
tive antagonist of LIGHT binding to HVEM (Mauri et al.,
998). The prominent expression of HVEM on T cells may
rovide HSV with a direct route to infect and inactivate
ells important in mounting an adaptive immune re-
ponse. Support for this hypothesis comes from the fact
hat HSV infection of T cells induces their death by a Fas
igand-dependent pathway. Additionally, infection of den-
ritic cells by HSV blocks their maturation into compe-
ent antigen-presenting cells. Thus, HSV may achieve
ocalized immune suppression by these mechanisms.
FIG. 2. Virus modulators of the TNF superfamily. Some examples of v
protein expressed by HIV (HIV Nef) sustains the expression of TNF and
I and CD4 (Lama and Ware, 2000). Herpes simplex virus envelope glyco
LIGHT (Mauri et al., 1998). The myxoma T2 protein encodes a soluble T
T2 is a virulence factor for rabbit poxvirus and similar gene products a
virus (LMP-1 EBV) is a six-transmembrane protein that binds the T
onstitutively active receptor, most similar to CD40 (Mosialos et al., 19
0.4K, 14.5K, and 6.7K (AdE3-10.4/14.5/6.7) form a multimeric membran
s necessary for downregulation of TRAIL receptors 1 and 2, but not d
omplex (Benedict et al., 2001b). The UL144 open reading frame in hum
eceptor 2 containing two cysteine-rich domains (Benedict et al., 1999).
odulates signaling (Matsumoto et al., 1997). Viral FLIP, found in so
locking apoptosis signaling by Fas and TRAIL receptors (Bertin et alhe latent membrane protein-1 of Epstein–Barr virus
g-herpesvirus) usurps the signaling adaptors TRAF2
i
and -3 and TRADD, leading to potent activation of NFkB
n B cells. The virus-encoded FLIP (vFLIP) of equine
g-herpesvirus, an antagonist of caspase-8 activation,
blocks apoptosis by Fas and TRAIL receptors similar to
its cellular homologue cFLIP. Additional evidence for
targeting of the TNF family by herpesvirus is the UL144
open reading frame present in human cytomegalovirus
(b-herpesvirus; HCMV), which encodes an orthologue of
VEM and TRAIL receptor type 2. A ligand for this re-
eptor has not been identified.
We reasoned that these diverse molecular links reflect
specific evolutionary history between the LT/TNF cyto-
ines and herpesviridae. Herpesviruses establish a life-
ong coexistence with their hosts that requires active
articipation of the immune system to control the primary
nfection and prevent reactivation from latency. The abil-
teins that modulate ligand-receptor signaling pathways are given. Nef
on the membrane of activated T cells as it downregulates MHC class
D (gD HSV) binds to HVEM, which blocks binding to its cellular ligand
ptor that binds TNF and LTa with high affinity (McFadden et al., 1997).
d in other poxviruses. The latent membrane protein-1 of Epstein–Barr
nd TRADD adaptors activating NFkB pathways, characteristic of a
P1 is the dominant oncogene of EBV. Adenovirus E3 region proteins
lex. E3-10.4K and 14.5K are sufficient to internalize Fas; however, 6.7K
omain receptors DR3 and TNFR1. Apoptosis is blocked by this AdE3
tomegalovirus (UL144 CMV) encodes an ortholog of HVEM and TRAIL
tis C virus core protein (HCV core) binds to LTbR, TNFR1, and Fas and
erpesviruses, blocks recruitment of caspase-8 (cas8) to FADD, thus
.iral pro
LIGHT
protein
NF rece
re foun
RAFs a
95). LM
e comp
eath d
an cy
Hepatity of proapoptotic TNF family ligands (TNF, Fas ligand,
nd TRAIL) to induce premature death of infected cells,
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4 MINIREVIEWthereby interrupting completion of the viral replication
cycle, may provide an effective antiviral defense against
some pathogens. However, rapid or large-scale destruc-
tion of crucial tissues harboring infected cells could be
detrimental to host survival, for example in the liver or
brain. Noncytolytic mechanisms exist to clear or at least
control viral replication such as seen in the control of
hepatitis B virus infection in the liver (Guidotti and
Chisari, 2000).
HOST VIRUS DE´TENTE
These observations prompted an examination of
whether LT/TNF-related cytokines elicit nonapoptotic re-
sistance to herpesvirus infection (Benedict et al., 2001a).
s a model, human CMV infection was examined in
ermal fibroblasts, one of the few cell types that allows
productive infection in culture. The investigation re-
ealed the ability of LT-related cytokines to mediate a
onapoptotic block of viral replication that requires both
CMV and host factors to arrest virus spread, yet viral
enome is preserved without detriment to the cell. Treat-
ent of HCMV-infected fibroblasts with the LT-related
igands LTa1b2 and LIGHT, which activate LTbR, or
LTa3, which binds TNFR1, inhibited cytopathicity and
spread of HCMV in cultures of dermal fibroblasts. Nei-
ther Fas ligand nor TRAIL exhibited this antiviral activity.
Dominant negative mutants of FADD or TRAF3, adaptors
required for apoptosis mediated by these receptors,
showed no inhibition of the antiviral effects of LT/LIGHT.
The antiviral effect of LT/LIGHT was reversible and, as
deduced from studies using dominant negative signaling
mutants, required the NFkB-dependent activation of in-
erferon-b (IFN-b) gene expression. However, efficient
nduction of IFN-b required virus infection and LT recep-
tor signaling, demonstrating the need for both host and
viral factors in the curtailment of viral replication without
cellular elimination. Neither virus infection alone nor ac-
tivation of the LT receptors induced significant IFN-b
production. The viral genome was maintained without
virion production for 2 weeks without any evidence of
cytopathic effects toward the fibroblasts; however, re-
moval of LT or neutralization of IFN-b reversed the anti-
viral effect and reinitiated virus replication and virion
production. The dependence on virus and lymphotoxin to
induce IFN-b may provide, in part, a molecular basis for
he ability of HCMV to establish a state of coexistence, or
e´tente, in immunocompetent hosts. Furthermore, the
bility of LTab, a product of activated TH1, CD8, and NK
cells, to selectively induce IFN-b gene expression may
eflect an additional component of the IFN amplification
athway. The potent immunoregulatory actions of IFN-ab
may then contribute to shaping the immune response
(Biron, 2001).Interestingly, LTa-deficient mice showed a profound
usceptibility to murine CMV, as did animals that ex-
Bressed a decoy receptor for LTa1b2 and LIGHT. This
bservation appears to substantiate the idea that CMV
nd lymphotoxins share significant evolutionary history.
et, we cannot say whether the mechanisms of action of
T in controlling the two species of CMV are similar,
ecause the species-restricted evolutionary divergence
f MCMV and HCMV is substantial. Indeed, the molec-
lar mechanisms of immune evasion strategies diverge
etween human and mouse CMV. Although their ge-
omes are colinear and highly conserved, the recog-
ized mechanisms used to modulate immunity, including
hose we suspect are involved in altering antigen pre-
entation pathways, chemokines, and cytokines, are not
onserved. For example, there is no UL144 homolog in
CMV, and although both human and mouse CMV en-
ode chemokine homologs, the viral chemokines are of
ifferent subtypes. The species specificity presents an
mportant impediment to understanding the significance
f viral evasion mechanisms. Are these evasion mecha-
isms important for viral pathogenesis? In the case of
he poxvirus TNFR decoy, deletion of this gene substan-
ially attenuates the lethal pathogenesis of myxoma in
abbits. Frankly, however, our knowledge is limited, as
any of the viruses are unique human pathogens that
orce reliance on tissue culture models. Nonetheless, we
ake the view that understanding these processes may
eveal further insight into viral pathogenesis and hope
he lessons learned from various viral strategies will
rovide new approaches for modulating cytokine path-
ays.
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